News

Jetrea is a selective proteolytic enzyme that cleaves fibronectin, laminin and collagen, three major components of the vitreoretinal interface that play a major role in VMA. The Ocriplasmin

The deal will see the companies provide a wider range of drug discovery and translational medicine services, including expanded profiling and molecule testing, especially in the context of

CFFT is the non-profit drug discovery and development affiliate of the Cystic Fibrosis Foundation. The extension will focus on moving the company’s lead compounds toward a development candidate

The company said that the licence agreement is with the same partner that will be supplying the women’s health product that is being prepared for launch in the

The company has announced this voluntary recall to the user level following the discovery of four leaking premix bags during an investigation conducted in response to a product

At the ChanTest headquarters in Cleveland, Ohio, the company has expanded its physical footprint by more than 50%. The laboratory expansion reflects the importance of providing high quality

Through partnership with Seoul National University Hospital (SNUH), the new Asian office is located within the SNUH Clinical Trials Center. This enables Celerion and its clients access to

This patent provides protection until 2031, not including any patent term extension. The patent complements Synageva’s existing and planned global patent portfolio covering its LAL deficiency program, which

Xenetic, in collaboration with the Massachusetts Life Sciences Center (MLSC) and the Massachusetts Biotechnology Council (MassBio), will host a grand opening and ribbon cutting ceremony to celebrate the